Home
Search:
1146 feeds
357 categories
2935 articles (<24 hours)
25 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsGenmab Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer
(WorldNews Denmark)

 
 

30 june 2020 03:57:44

 
Genmab Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer
(WorldNews Denmark)
 


Genmab A/S Inside information Genmab Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer Company Announcement Genmab and Seattle Genetics plan to discuss the results with the U.S. Food and Drug Administration (U.S. FDA) Full data to be presented at an upcoming medical meeting Copenhagen, Denmark; June 29, 2020 - Genmab A/S (Nasdaq: GMAB) today announced very favorable topline results from the Phase 2 single-arm clinical trial known as innovaTV 204 evaluating tisotumab vedotin administered every three weeks for the treatment of patients who have relapsed or progressed on or after prior treatment for recurrent or...


 
58 viewsCategory: General > Europe > Denmark
 
The Board of Directors of NoHo Partners decided to grant 2.4 million special rights to Finnish Industry Investment Ltd as a part of the financing package completed earlier
(WorldNews Denmark)
Update - Gefion Insurance A/S
(WorldNews Denmark)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2020 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten